Advertisement

Advertisement

DE:2BO Stock Latest News

Serina Therapeutics: Early SER-252 Efficacy Signal and Strategic Positioning Support Unchanged $8 Price Target and Buy Rating

RatingsSerina Therapeutics: Early SER-252 Efficacy Signal and Strategic Positioning Support Unchanged $8 Price Target and Buy Rating

Serina Therapeutics Establishes Flexible Equity Financing Agreement

PremiumCompany Announcements

Serina Therapeutics Establishes Flexible Equity Financing Agreement

1M ago

Serina Therapeutics files to sell 12.5M shares of common stock for holders

PremiumThe Fly

Serina Therapeutics files to sell 12.5M shares of common stock for holders

1M ago

Serina Therapeutics: Buy Rating Reiterated, $11 Price Target Maintained on Strong SER-252 Clinical Progress

PremiumRatings

Serina Therapeutics: Buy Rating Reiterated, $11 Price Target Maintained on Strong SER-252 Clinical Progress

2M ago

SER Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

SER Earnings Report this Week: Is It a Buy, Ahead of Earnings?

2M ago

Serina Therapeutics Amends CEO Employment and Compensation Terms

PremiumCompany AnnouncementsSerina Therapeutics Amends CEO Employment and Compensation Terms

3M ago

Serina Therapeutics completes enrollment and dosing in Parkinson’s trial

The Fly

Serina Therapeutics completes enrollment and dosing in Parkinson’s trial

3M ago

Serina Therapeutics Adds Industry Veteran to Board

Company Announcements

Serina Therapeutics Adds Industry Veteran to Board

3M ago

Serina Therapeutics appoints Trevi Therapeutics CCO Farrell Simon to board

PremiumThe Fly

Serina Therapeutics appoints Trevi Therapeutics CCO Farrell Simon to board

3M ago

Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252

PremiumThe Fly

Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252

3M ago

Serina Therapeutics initiated with a Buy at BTIG

PremiumThe Fly

Serina Therapeutics initiated with a Buy at BTIG

3M ago

Serina Therapeutics Shareholders Approve Expanded Equity and Governance

PremiumCompany Announcements

Serina Therapeutics Shareholders Approve Expanded Equity and Governance

4M ago

Serina Therapeutics files to sell 16.45M shares of common stock for holders

PremiumThe FlySerina Therapeutics files to sell 16.45M shares of common stock for holders

5M ago

Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks

Company Announcements

Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks

5M ago

Serina Therapeutics Updates Executive Leadership and Governance Structure

Company Announcements

Serina Therapeutics Updates Executive Leadership and Governance Structure

6M ago

Serina Therapeutics announces NYSE acceptance of plan to regain compliance

PremiumThe Fly

Serina Therapeutics announces NYSE acceptance of plan to regain compliance

6M ago

Serina Therapeutics Announces Premium Private Placement Financing

PremiumCompany Announcements

Serina Therapeutics Announces Premium Private Placement Financing

7M ago

Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)

PremiumTipRanks Newswire

Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)

7M ago

Serina Therapeutics names Greg Bailey co-chairman

PremiumThe Fly

Serina Therapeutics names Greg Bailey co-chairman

7M ago

Serina Therapeutics doses first patient in SER-252 trial

PremiumThe FlySerina Therapeutics doses first patient in SER-252 trial

7M ago

Serina Therapeutics says first patient enrolled in Phase 1b trial of SER-252

The Fly

Serina Therapeutics says first patient enrolled in Phase 1b trial of SER-252

8M ago

Serina Therapeutics files to sell 7.72M shares of common stock for holders

The Fly

Serina Therapeutics files to sell 7.72M shares of common stock for holders

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >